MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2019 International Congress

    Huntington’s Disease Protein Huntingtin Associates with its own mRNA

    M. Rakhimova, M. Daropova (Tashkent, Uzbekistan)

    Objective: To investigate how Htt might affect RNA metabolism we set out to purify and analyze RNA associated with Htt. Background: The Huntington's disease (HD)…
  • 2019 International Congress

    Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort

    A. Siderowf, T. Simuni, M. Brumm, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Chicago, IL, USA)

    Objective: To compare baseline clinical and imaging characteristics of the GBA and LRRK2 PD manifest cohorts to PD sporadic (sPD) cohort. Background: The phenotype and…
  • 2019 International Congress

    Correlation between structural neuroimaging and clinical outcomes in a small sample of patients with early Huntington’s disease

    C. Estevez Fraga, E. Johnson, F. Rodrigues, P. Zeun, N. Hobbs, E. Rees, R. Roos, B. Landwehrmeyer, A. Durr, S. Gregory, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

    Objective: Scores on the symbol digit modalities test (SDMT), Stroop word-reading, Total Motor Score (TMS) and composite UHDRS (cUHDRS) are correlated with disease progression and…
  • 2019 International Congress

    Mobility Impairments in Huntington’s Disease due to Cognitive Dysfunction

    M. Rakhimova, N. Yusupova (Tashkent, Uzbekistan)

    Objective: This study examined the relationships of mobility, motor and cognitive function measures at baseline, and of mobility and cognitive measures over four years Background:…
  • 2019 International Congress

    Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort

    A. Siderowf, T. Simuni, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollehauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Philadelphia, PA, USA)

    Objective: To examine baseline clinical and dopamine transporter (DAT) imaging characteristics in a cohort of non-manifest carriers (NMC) of GBA and LRRK2 compared to healthy…
  • 2019 International Congress

    Cerebellar Ataxia in Patients with Huntington’s Disease, an underestimated symptom?

    GLF. Franklin, HAT. Teive, FBG. Germiniani, SR. Raskin, GMP. Pavanelli, SSM. Milano, NSL. Lima, OPB. Barsottini, JLP. Pedroso, FAM. Maggi, VT. Tumas, PMC. Carvalho, PCA. Azevedo, ILC. Lopes-Cendes (Curitiba, Brazil)

    Objective: To analyze the prevalence of cerebellar ataxia in patients with Huntington’s Disease (HD), both early and late on HD progression and correlating the degree…
  • 2019 International Congress

    Factors underlying reduced aerobic capacity in Huntington disease

    A. Rao, S. Norris, J. Montes, P. Wasserman, K. Marder (New York, NY, USA)

    Objective: Examine factors underlying aerobic capacity in prodromal and manifest Huntington disease (HD) and matched controls Background: HD results in motor impairments, weight loss, muscle…
  • 2019 International Congress

    Acute hemichorea caused by infarction over globus pallidus interna

    YP. Chang (Kaohsiung, Taiwan)

    Objective: To report a case of acute hemichorea after infarction over globus pallidus interna Background: Movement disorders occurred after stroke have been recognized in previous…
  • 2019 International Congress

    Homozygous Huntington’s disease with two reduced penetrance alleles: A Case Report

    K. Grimm, C. Zühlke, C. Gerloff, S. Zittel (Hamburg, Germany)

    Objective: To clinically characterize a Huntington's disease patient with two reduced penetrance alleles. Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder manifesting with…
  • 2019 International Congress

    Subcortical atrophy is an early event in Huntington’s disease

    N. Rocha, L. Latham, O. Charron, G. Papadimitropoulos, G. Colpo, L. Freeman, E. Furr Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To determine whether brain regional volumes are associated with clinical symptoms in premanifest and manifest Huntington’s disease (HD). Background: Striatal atrophy has been considered a…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #26133 (not found)
  • #23951 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley